Valuation: IMAC Holdings, Inc.

Market Cap 526K 462K 437K 397K 745K 50.47M 749K 5.24M 2.02M 25.75M 1.97M 1.93M 82.75M P/E 2023
-0.26x
P/E 2024 -0.22x
Enterprise Value 21.54K 18.95K 17.92K 16.25K 30.52K 2.07M 30.7K 215K 82.85K 1.06M 80.88K 79.13K 3.39M EV / Sales 2023
-
EV / Sales 2024 28.5x
Free-Float
98.48%
Yield 2023 *
-
Yield 2024 -
1 day-11.63%
1 week+6,233.33%
Current month+7,500.00%
1 month+7,500.00%
3 months-20.00%
6 months-33.68%
Current year-72.64%
1 week 0
Extreme 0.0006
0.04
1 month 0
Extreme 0.0005
0.04
Current year 0
Extreme 0.0002
0.15
1 year 0
Extreme 0.0002
0.21
3 years 0
Extreme 0.0002
7.75
5 years 0
Extreme 0.0002
45.3
10 years 0
Extreme 0.0002
216.15
Manager TitleAgeSince
Chief Executive Officer 51 2024-05-22
Director of Finance/CFO 57 2019-04-29
Director TitleAgeSince
Director/Board Member 46 2020-10-20
Director/Board Member 66 2024-06-25
Director/Board Member 51 2024-06-25
Date Insider Type Main position Quantity % Market Cap. Importance
12/31/24 Free

Director

3,333 0.1936%
12/31/24 Free

Director

3,333 0.1936%
12/31/24 Free

Director

3,333 0.1936%
Change 5-day change 1-year change 3-year change Capi.($)
-11.63%+6,233.33%-53.66%-97.89% 2.27K
-0.33%-0.58%+17.98%+76.49% 13.34B
+0.45%+2.02%-2.12%+83.54% 12.18B
-0.63%-3.08%-36.36%-56.26% 10.92B
+0.67%+1.08%+2.24%+87.68% 10.12B
-0.69%-3.30% - - 9.98B
-1.98%-0.50%-3.41%-25.28% 9.61B
+0.20%+0.23%+76.21%+7.25% 8.94B
+0.35%+1.40%+2.12% - 8.71B
-1.59%-1.24%+19.56%+128.97% 6.9B
Average -1.53%+0.52%+2.51%+25.56% 9.07B
Weighted average by Cap. -0.35%+0.45%+7.95%+41.97%

Financials

2023 2024
Net sales - 72.05K 63.37K 59.92K 54.35K 102K 6.92M 103K 717K 277K 3.53M 271K 265K 11.34M
Net income -9.42M -8.28M -7.83M -7.1M -13.34M -904M -13.42M -93.79M -36.22M -461M -35.36M -34.6M -1.48B -9.05M -7.96M -7.52M -6.82M -12.81M -868M -12.89M -90.08M -34.79M -443M -33.96M -33.23M -1.42B
Net Debt -222K -195K -184K -167K -314K -21.26M -316K -2.21M -852K -10.85M -832K -814K -34.87M -504K -443K -419K -380K -714K -48.4M -718K -5.02M -1.94M -24.7M -1.89M -1.85M -79.36M
Logo IMAC Holdings, Inc.
IMAC Holdings, Inc. provides services related to proteomic products that identify and support oncology clinical treatment decisions and biopharmaceutical drug development. The Company, through its subsidiary, Ignite Proteomics LLC (Ignite Proteomics), leverages its multi-analyte proteomic assay to help oncologists pinpoint the effective targeted therapies for each patient. Its product is a patented Reverse Phase Protein Array (RPPA) technology platform, which can quantify protein signaling to support oncology clinical treatment decisions and biopharmaceutical drug development. Ignite Proteomics operates a CLIA-certified and CAP-accredited laboratory and offers single-gene tests by evaluating entire protein pathways in cancer cells. Its commercially available lab developed test (LDT), the Ignite RPPA Assay for Breast Cancer, is being utilized by oncologists across the United States to assist in making the targeted treatment plan for their patients with advanced breast cancer.
Employees
15
Date Price Change Volume
26-09-25 US$0.000600 -.--% 1,000

Annual profits - Rate of surprise

  1. Stock Market
  2. Stocks
  3. BACK Stock